Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCGW.L Regulatory News (CGW)

  • There is currently no data for CGW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

9 Jan 2012 11:34

CHELVERTON GROWTH TRUST PLC

INTERIM MANAGEMENT STATEMENT

For the period ended 30 November 2011

INVESTMENT OBJECTIVE

The investment objective of the Company is to provide capital growth through investment in companies listed on the Official List and traded on the Alternative Investment Market (`AIM') with a market capitalisation at the time of investment of up to £50 million, which are believed to be at a `point of change'. Its investment objective is to increase net asset value per share at a higher rate than other quoted smaller company trusts and the FTSE All-Share Index.

INVESTMENT POLICY

The Company invests principally in securities of publicly quoted UK companies, though it may invest in unquoted securities. The concentrated UK portfolio comprises between 20 to 35 securities. The performance of the Company's investments is compared to the FTSE All-Share Index. The Company will also invest in unquoted investments where it is believed that there is a likelihood of the shares becoming listed or traded on AIM or the investee company being sold. The Company will not invest in any listed investment companies or listed investment trusts.

It is intended from time to time, when deemed appropriate, that the Company will borrow for investment purposes, it currently has no borrowings.

The investment objective and policy stated above are intended to distinguish the Company from other investment vehicles which have relatively narrow investment objectives and which are constrained in their decision making and asset allocation. The objective and policy allow the Company to be constrained in its investment selection only by valuation and to be pragmatic in portfolio construction by only investing in securities which the Investment Manager considers to be undervalued on an absolute basis.

KEY FACTS

Net asset value (NAV) per Ordinary 31.40p share* Ordinary share price 24.00p Discount 23.57% PERFORMANCE - TOTAL RETURN

For the period ended 30 November 2011

NAV* 2.61% Share Price 9.09% FTSE All Share Index 2.11% FTSE Small-Cap Index (8.12%)

*Based on NAV including current period revenue

MATERIAL DEVELOPMENTSANDTRANSACTIONS

On 21 December 2011 Shareholders passed all resolutions at the Company's Annual General Meeting and accordingly approved the resolution pertaining to the proposed Tender Offer and Buyback.

As announced on 28 December 2011 and pursuant to the Tender Offer, 1,323,334Ordinary shares and to the buyback offer, 25,727 Ordinaryshares will be repurchased for cancellation with settlement on 23 January 2012.

As a result of the above, there will be 11,884,283 Ordinary shares of 1p each in issue. The above figure may be used from 23 January 2012, by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.

DISTRIBUTION OF ASSETS AND LIABILITIES

30 November 2011 31 August 2011 £'000 £'000 AIM traded investments - Ordinary 3,660 3,576 shares Delisted and unquoted 457 479 4,117 4,055 Current assets/(liabilities) 38 (6) Net assets 4,155 4,049 Net asset value per Ordinary share 31.40p 30.60p Name of company % of portfolio 1 IDOX 33.47 2 AI Claims Solutions 13.27 3 Parmenion Capital Partners LLP 9.66 4 Belgravium Technologies 7.29 5 Alliance Pharma 6.63 6 CEPS 4.85 7 Tristel 3.69 8 PSG Solutions 3.67 9 Pennant International Group 2.94 10 Northbridge Industrial Services 2.71 11 LPA Group 2.60 12 Titan Europe 2.26 13 Sanderson Group 1.89 14 One Horizon Group 1.44 15 Datong Electronics 1.16 16 MTI Wireless Edge 1.10 17 Richoux Group 0.88 18 Petards Group 0.28 19 Universe Group 0.21 Balance held in 3 holdings 0.00 100.00

Note: The Directors are not aware of any significant events or transactions which have occurred between the date of the financial information and the date of publication, which would have a material impact on the financial position of the Company.

The net asset value is published on a monthly basis and other useful background information on the Company including downloads of published documentation such as previous Annual Reports and Monthly Fact Sheets can be found at www.chelvertonam.com .

COMPANY INFORMATIONLaunch date: 12 May 1999Year end: 31 AugustResults announced:Half-year - AprilFinal - NovemberAGM - December

Price information is published in the Financial Times under 'Investment Companies'.

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency rules. It should not be relied upon by any other party or for any other purposes. In addition, the views, information and data in this publication should not be deemed as a financial promotion or recommendation.

Contact:

William van Heesewijk

Chelverton Asset Management Limited

Tel: 0207 222 8989

XLON
Date   Source Headline
27th Nov 20233:42 pmRNSResult of Meeting
27th Nov 202310:30 amRNSSuspension - Chelverton Growth Trust plc
14th Nov 202312:36 pmRNSNet Asset Value(s)
1st Nov 20237:00 amRNSPublication of Circular and Notice of GM
9th Oct 20232:27 pmRNSNet Asset Value(s)
11th Sep 20234:41 pmRNSNet Asset Value(s)
25th Aug 20237:00 amRNSNet Asset Value(s)
4th Aug 202311:25 amRNSHolding(s) in Company
31st Jul 20239:59 amRNSHolding(s) in Company
31st Jul 20239:55 amRNSHolding(s) in Company
17th Jul 202311:02 amRNSNet Asset Value(s)
13th Jun 202310:28 amRNSNet Asset Value(s)
10th May 202311:09 amRNSNet Asset Value(s)
24th Apr 20237:00 amRNSHalf-year Report
6th Apr 20237:00 amRNSNet Asset Value(s)
20th Mar 20235:46 pmRNSDirector/PDMR Shareholding
3rd Mar 20235:03 pmRNSNet Asset Value(s)
6th Feb 20237:00 amRNSNet Asset Value(s)
16th Jan 20232:56 pmRNSHolding(s) in Company
16th Jan 202310:58 amRNSNet Asset Value(s)
15th Dec 20222:06 pmRNSResult of AGM
7th Dec 20221:11 pmRNSNet Asset Value(s)
10th Nov 20227:00 amRNSNet Asset Value(s)
9th Nov 20227:00 amRNSFinal Results
11th Oct 202210:55 amRNSNet Asset Value(s)
23rd Sep 20227:00 amRNSNet Asset Value(s)
5th Aug 202211:56 amRNSNet Asset Value(s)
6th Jul 202212:53 pmRNSNet Asset Value(s)
13th Jun 202212:40 pmRNSNet Asset Value(s)
16th May 20223:52 pmRNSNet Asset Value(s)
14th Apr 20223:12 pmRNSHalf-year Report
6th Apr 20227:00 amRNSNet Asset Value(s)
21st Mar 20227:00 amRNSNet Asset Value(s)
10th Feb 202211:43 amRNSNet Asset Value(s)
12th Jan 20225:52 pmRNSNet Asset Value(s)
11th Jan 20221:03 pmRNSResult of AGM
20th Dec 20213:11 pmRNSNet Asset Value(s)
16th Nov 20211:51 pmRNSFinal Results
9th Nov 20212:48 pmRNSNet Asset Value(s)
6th Oct 202110:03 amRNSNet Asset Value(s)
30th Sep 20215:32 pmRNSHolding(s) in Company
27th Sep 20212:38 pmRNSNet Asset Value(s)
12th Aug 202112:27 pmRNSNet Asset Value(s)
11th Aug 20212:52 pmRNSHolding(s) in Company
11th Aug 20212:48 pmRNSHolding(s) in Company
6th Jul 20214:42 pmRNSNet Asset Value(s)
5th Jul 20211:56 pmRNSHolding(s) in Company
10th Jun 20213:28 pmRNSHolding(s) in Company
9th Jun 202112:01 pmRNSDirector/PDMR Shareholding
9th Jun 202111:59 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.